These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1177487)

  • 1. The influence of cardiopulmonary bypass on the size of human platelets.
    Laufer N; Merin G; Grover NB; Pessachowicz B; Borman JB
    J Thorac Cardiovasc Surg; 1975 Oct; 70(4):727-31. PubMed ID: 1177487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation: effects of cardiopulmonary bypass.
    Solis RT; Beall AC; Noon GP; DeBakery ME
    Chest; 1975 May; 67(5):558-63. PubMed ID: 1126194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass.
    Muriithi EW; Belcher PR; Rao JN; Chaudhry MA; Nicol D; Wheatley DJ
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):538-43. PubMed ID: 10962416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood platelets and extracorporeal circulation; kinetic studies on dogs on cardiopulmonary bypass.
    de Leval MR; Hill JD; Mielke CH; Macur F; Gerbode F
    J Thorac Cardiovasc Surg; 1975 Jan; 69(1):144-51. PubMed ID: 1110575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation.
    Zilla P; Fasol R; Groscurth P; Klepetko W; Reichenspurner H; Wolner E
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):379-88. PubMed ID: 2918735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator.
    Addonizio VP; Strauss JF; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1979 Jan; 77(1):119-26. PubMed ID: 102876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
    van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet support for cardiopulmonary bypass surgery.
    Harding SA; Shakoor MA; Grindon AJ
    J Thorac Cardiovasc Surg; 1975 Aug; 70(2):350-3. PubMed ID: 1097840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet size and mass as an indicator for platelet transfusion after cardiopulmonary bypass.
    Mohr R; Martinowitz U; Golan M; Ayala L; Goor DA; Ramot B
    Circulation; 1986 Nov; 74(5 Pt 2):III153-8. PubMed ID: 3769188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.
    Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation: prevention with prostaglandin E1.
    Wachtogel YT; Musial J; Jenkin B; Niewiarowski S; Edmunds LH; Colman RW
    J Lab Clin Med; 1985 May; 105(5):601-7. PubMed ID: 4039346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
    Blauhut B; Gross C; Necek S; Doran JE; Späth P; Lundsgaard-Hansen P
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):958-67. PubMed ID: 1710008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
    Kondo N; Suzuki Y; Wakayama F; Tamai Y; Ji K; Fukui K; Fukuda I
    Ann Thorac Surg; 2005 Jul; 80(1):251-7. PubMed ID: 15975376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.
    Ballotta A; Saleh HZ; El Baghdady HW; Gomaa M; Belloli F; Kandil H; Balbaa Y; Bettini F; Bossone E; Menicanti L; Frigiola A; Bellucci C; Mehta RH
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):132-8. PubMed ID: 17599498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients.
    Holloway DS; Summaria L; Sandesara J; Vagher JP; Alexander JC; Caprini JA
    Thromb Haemost; 1988 Feb; 59(1):62-7. PubMed ID: 2452492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations.
    Fish KJ; Sarnquist FH; van Steennis C; Mitchell RS; Hilberman M; Jamieson SW; Linet OI; Miller DC
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators.
    Peterson KA; Dewanjee MK; Kaye MP
    J Thorac Cardiovasc Surg; 1982 Jul; 84(1):39-43. PubMed ID: 7087539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
    Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
    Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.